• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [19518 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Center for Evidence-based Practice (CEP) COVID-19: corticosteroids for hospitalized patients
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Alpha1-proteinase inhibitor (Prolastin-C) for the treatment of alpha1-antitrypsin deficiency: a review of economic evaluations
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: The Argus II retinal implant]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate pharmacotherapy for inflammatory bowel disease
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) HPV testing for primary cervical cancer screening: a health technology assessment
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: a health technology assessment
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Axicabtagene ciloleucel for large B-cell lymphoma: clinical report
2019     NIHR Health Technology Assessment programme Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Ivabradine for heart failure
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Hemlibra (Emicizumab): economic review report
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Hemin for injection (Panhematin): budget impact analysis
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness and safety of epicardial closure of left atrial appendage using clips by minimally invasive surgery for thromboembolism prevention in patients with atrial fibrillation]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Genome-wide sequencing: ethical considerations
2019     NIHR Health Technology Assessment programme Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Validity, clinical utility and safety of the next-generation sequencing (NGS) genomic platform FoundationOne® in non-small cell lung cancer and other solid tumors]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug therapies for the long-term prophylaxis of hereditary angioedema attacks
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Flash glucose monitoring system for people with type 1 or type 2 diabetes: a health technology assessment
2019     NIHR Horizon Scanning Centre (NIHR HSC) An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     Norwegian Institute of Public Health (NIPH) Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: breast tomosynthesis and breast cancer screening]
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Dosing and timing of immuno-oncology drugs
2019     NIHR Health Technology Assessment programme Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019     Norwegian Institute of Public Health (NIPH) Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019     Norwegian Institute of Public Health (NIPH) Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019     Norwegian Institute of Public Health (NIPH) Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019     Haute Autorite de sante (HAS) [Assessment of pulp wound protection by direct pulp capping]
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019     Norwegian Institute of Public Health (NIPH) Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019     Norwegian Institute of Public Health (NIPH) Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     Norwegian Institute of Public Health (NIPH) Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Canagliflozin, empagliflozin and dapagliflozin in type 2 diabetes patients]
2019     Norwegian Institute of Public Health (NIPH) Hyperbaric oxygen therapy for osteonecrosis
2019     NIHR Public Health Research (PHR) programme Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2019     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) [Surgical smoke during operations - the risks to personnel, and the protective measures needed]
2019     Adelaide Health Technology Assessment (AHTA) Alpha Thalassaemia genetic testing
2019     NIHR Health Technology Assessment programme Developing and evaluating a tool to measure general practice productivity: a multimethod study
2019     NIHR Health Technology Assessment programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Axicabtagene ciloleucel (PMBCL)]
2019     Swiss Federal Office of Public Health (FOPH) Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2019     NIHR Health Technology Assessment programme An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes: rapid evidence synthesis
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Bevacizumab in age-related macular degeneration]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Thiazolidinediones for type 2 diabetes mellitus]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Canagliflozin, empagliflozin and dapagliflozin (SGLT-2) for patients with type 2 diabetes]
2019     NIHR Health Technology Assessment programme A peer-led physical activity intervention in schools for adolescent girls: a feasibility RCT
2019     Andalusian Health Technology Assessment Area (AETSA) [Blood test for the early diagnosis of pancreatic cancer. CancerSEEK]
2019     NIHR Health Technology Assessment programme MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study
2019     Andalusian Health Technology Assessment Area (AETSA) [Post-introduction observational study of predictive/prognostic tests in breast cancer of the Andalusian Public Health System (SSPA)]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Pirfenidone in pulmonary fibrosis]
2019     NIHR Health Technology Assessment programme Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT
2019     NIHR Health Services and Delivery Research programme Improving NHS quality using internet ratings and experiences (INQUIRE)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyaluronic acid dermal fillers in skin repair procedures]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Alirocumab for patients with hypercholesterolemia]
2019     NIHR Health Technology Assessment programme Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [PET-CT in patients with head and neck cancer diagnosis]
2019     NIHR Health Technology Assessment programme Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT
2019     NIHR Health Services and Delivery Research programme Evaluation of specialist nursing support for carers of people with dementia
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Relex® SMILE® surgery for refractive errors]
2019     NIHR Health Services and Delivery Research programme Understanding and enhancing how hospital staff learn from and act on patient experience data
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Liraglutide in obese and overweight patients]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Respiratory polygraphy for obstructive sleep apnea syndrome]
2019     NIHR Health Services and Delivery Research programme A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Thiazolidinediones for type 2 diabetes mellitus]
2019     NIHR Health Technology Assessment programme Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study
2019     NIHR Health Technology Assessment programme Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Positron-emission tomography for breast cancer]
2019     NIHR Health Technology Assessment programme A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT
2019     Center for Evidence-based Practice (CEP) The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Center for Evidence-based Practice (CEP) Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Kinanthropometric nutritional assessment]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Center for Evidence-based Practice (CEP) Guidelines for Supplementary Feedings of Newborn Infants
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [High frequency chest compression vest for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2019     NIHR Health Technology Assessment programme Developing an intervention around referral and admissions to intensive care: a mixed-methods study
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Cerliponase alfa in neuronal ceroid lipofuscinosis type 2]
2019     NIHR Health Technology Assessment programme Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) as first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) with nab-paclitaxel (Abraxane®) for the treatment of advanced triple-negative breast cancer (aTNBC)
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Prolotherapy in chronic musculoskeletal disorders]
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections. EUnetHTA-Report
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous cement discoplasty for the treatment of degenerative scoliosis in the elderly]